CORT
Price:
$84.66
Market Cap:
$8.91B
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advance...[Read more]
Industry
Biotechnology
IPO Date
2004-04-14
Stock Exchange
NASDAQ
Ticker
CORT
According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 97.31. This represents a change of 9.65% compared to the average of 88.74 of the last 4 quarters.
The mean historical PE Ratio of Corcept Therapeutics Incorporated over the last ten years is 20.76. The current 97.31 PE Ratio has changed 46.78% with respect to the historical average. Over the past ten years (40 quarters), CORT's PE Ratio was at its highest in in the June 2016 quarter at 153.73. The PE Ratio was at its lowest in in the March 2016 quarter at -6752.81.
Average
20.76
Median
21.83
Minimum
-83.00
Maximum
98.61
Discovering the peaks and valleys of Corcept Therapeutics Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 759.85%
Maximum Annual PE Ratio = 98.61
Minimum Annual Increase = -218.81%
Minimum Annual PE Ratio = -83.00
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 37.23 | 17.47% |
| 2023 | 31.69 | 48.19% |
| 2022 | 21.39 | 5.07% |
| 2021 | 20.35 | -28.54% |
| 2020 | 28.48 | 93.86% |
| 2019 | 14.69 | -34.02% |
| 2018 | 22.27 | 40.23% |
| 2017 | 15.88 | -83.90% |
| 2016 | 98.61 | -218.81% |
| 2015 | -83.00 | 759.85% |
The current PE Ratio of Corcept Therapeutics Incorporated (CORT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
30.10
5-year avg
27.83
10-year avg
20.76
Corcept Therapeutics Incorporated’s PE Ratio is greater than Halozyme Therapeutics, Inc. (12.39), greater than Abivax S.A. (-30.21), greater than Rhythm Pharmaceuticals, Inc. (-35.36), greater than Merus N.V. (-20.81), greater than Cytokinetics, Incorporated (-10.62), greater than Jazz Pharmaceuticals plc (-27.49), greater than Caris Life Sciences, Inc. (-36.95), greater than Axsome Therapeutics, Inc. (-32.26), greater than Nuvalent, Inc. (-20.21), greater than Avidity Biosciences, Inc. (-20.35),
| Company | PE Ratio | Market cap |
|---|---|---|
| 12.39 | $7.40B | |
| -30.21 | $8.36B | |
| -35.36 | $7.05B | |
| -20.81 | $7.30B | |
| -10.62 | $7.92B | |
| -27.49 | $10.14B | |
| -36.95 | $7.99B | |
| -32.26 | $7.46B | |
| -20.21 | $7.77B | |
| -20.35 | $9.39B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Corcept Therapeutics Incorporated's PE Ratio?
How is the PE Ratio calculated for Corcept Therapeutics Incorporated (CORT)?
What is the highest PE Ratio for Corcept Therapeutics Incorporated (CORT)?
What is the 3-year average PE Ratio for Corcept Therapeutics Incorporated (CORT)?
What is the 5-year average PE Ratio for Corcept Therapeutics Incorporated (CORT)?
How does the current PE Ratio for Corcept Therapeutics Incorporated (CORT) compare to its historical average?